Matt Tindall

Matt Tindall has a diverse work experience that spans multiple industries. Matt is currently the Founder and CEO of Flightpath Biosciences, Inc, a company focused on developing new bioscience technologies. In addition, they serve as an Advisor at Parallel Health, a healthcare organization.

Prior to their current roles, Tindall was an Advisor at Courage Health, a healthcare data company, where they contributed to the development of software for personalized survival rates for various types of cancer. Matt also co-founded Kodikaz Therapeutic Solutions, Inc, a biotechnology company specializing in gene editing technologies for cancer treatment.

Tindall has also held positions as an Executive-In-Residence at Grosvenor Food & AgTech, CEO at Fabric Genomics, General Manager at IQVIA, and VP of Marketing at Digitas Health. Matt started their career as a Strategy Consultant at Frankel Group. Earlier in their career, Tindall co-founded Sarentis Therapeutics, Inc., where they served as CEO.

Matt Tindall's education history includes an MBA degree in Finance and Entrepreneurship from the Texas McCombs School of Business, which they earned between 1999 and 2001. Prior to that, they attended the Michigan State University College of Natural Science from 1990 to 1995, where they obtained a BS degree in Human Physiology.